Gary Peter Tomkinson

Title: Gary Peter Tomkinson: Innovator in Pharmaceutical Chemistry

Introduction

Gary Peter Tomkinson is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. His work primarily focuses on the development of new chemical compounds and their applications in therapy.

Latest Patents

Among his latest patents is the invention concerning crystalline forms of (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide. This invention discloses new solid-state forms of the compound, processes for preparing these forms, pharmaceutical compositions that include them, and their therapeutic uses. Another significant patent involves chemical compounds of Formula (I) or pharmaceutically acceptable salts thereof, which are aimed at treating cell proliferative disorders.

Career Highlights

Gary Peter Tomkinson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Benedicte Delouvrie and Craig Steven Harris, enhancing the research and development efforts within his field.

Conclusion

Gary Peter Tomkinson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic solutions in medicine.